MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Operating Expenses 2011-2026 | ABT
Annual Operating Expenses Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 14.1 B | 14.2 B | 13.3 B | 8.64 B | 8.79 B | 8.43 B | 9.18 B | 16.4 B | 16.9 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.9 B | 8.43 B | 12.2 B |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
72.8 M | $ 8.98 | -1.32 % | $ 322 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.41 | 0.38 % | $ 121 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.32 | -2.02 % | $ 168 M | USA |
 |
IRadimed Corporation
IRMD
|
38.2 M | $ 100.97 | 1.78 % | $ 1.28 B | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 62.4 | -1.33 % | $ 3.4 B |  Britain |
 |
Medtronic PLC
MDT
|
15.3 B | $ 86.58 | -0.68 % | $ 111 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 11.72 | -1.26 % | $ 464 M |  Curacao |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.35 | - | $ 21.8 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Penumbra
PEN
|
753 M | $ 334.17 | -0.41 % | $ 13 B | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.56 | -8.4 % | $ 64 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 225.5 | -0.7 % | $ 15.9 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Profound Medical Corp.
PROF
|
33 M | $ 5.15 | -4.63 % | $ 180 M |  Canada |
 |
Quanterix Corporation
QTRX
|
191 M | $ 3.82 | -3.05 % | $ 163 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 32.61 | 2.71 % | $ 1.5 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.56 | -0.19 % | $ 1.13 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
40.3 M | $ 24.7 | 0.86 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.57 | 0.78 % | $ 7.13 M | USA |
 |
Sensus Healthcare
SRTS
|
22.2 M | $ 3.96 | -3.65 % | $ 64.7 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.7 | 3.3 % | $ 38.1 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 328.51 | -1.23 % | $ 126 B | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.48 | 10.7 % | $ 1.55 B | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 24.51 | -2.31 % | $ 1.67 B | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.7 | -1.83 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.4 | -1.64 % | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.91 | 4.83 % | $ 146 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.91 | -3.4 % | $ 373 M | USA |
 |
Outset Medical
OM
|
113 M | $ 3.53 | -2.35 % | $ 53.7 K | USA |